N,N-dimethyl-8-(3-sulfamoylanilino)-4,5-dihydro-[1,3]thiazolo[5,4-h]quinazoline-2-carboxamide
C18H18N6O3S2 — CID 59262738
Data last refreshed: (MolForge compound catalog, from PubChem)
About N,N-dimethyl-8-(3-sulfamoylanilino)-4,5-dihydro-[1,3]thiazolo[5,4-h]quinazoline-2-carboxamide
N,N-dimethyl-8-(3-sulfamoylanilino)-4,5-dihydro-[1,3]thiazolo[5,4-h]quinazoline-2-carboxamide (PubChem CID 59262738) has the molecular formula C18H18N6O3S2 and a molecular weight of 430.52 g/mol. Its IUPAC name is N,N-dimethyl-8-(3-sulfamoylanilino)-4,5-dihydro-[1,3]thiazolo[5,4-h]quinazoline-2-carboxamide.
Molecular Properties
| Compound Name | N,N-dimethyl-8-(3-sulfamoylanilino)-4,5-dihydro-[1,3]thiazolo[5,4-h]quinazoline-2-carboxamide |
|---|---|
| PubChem CID | 59262738 |
| Molecular Formula | C18H18N6O3S2 |
| Molecular Weight | 430.52 g/mol |
| Exact Mass | 430.09 |
| IUPAC Name | N,N-dimethyl-8-(3-sulfamoylanilino)-4,5-dihydro-[1,3]thiazolo[5,4-h]quinazoline-2-carboxamide |
| SMILES | CN(C)C(=O)c1nc2c(s1)CCc1cnc(Nc3cccc(S(N)(=O)=O)c3)nc1-2 |
| InChI | InChI=1S/C18H18N6O3S2/c1-24(2)17(25)16-22-15-13(28-16)7-6-10-9-20-18(23-14(10)15)21-11-4-3-5-12(8-11)29(19,26)27/h3-5,8-9H,6-7H2,1-2H3,(H2,19,26,27)(H,20,21,23) |
| InChIKey | OPWXVVUJDQJISV-UHFFFAOYSA-N |
| XLogP | 1.79 |
| TPSA | 131.17 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 430.52 |
| LogP ≤ 5 | 1.79 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 59262738 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.